Location: Greenwich, CT
CIK: 0001281446 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $242M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,700,000 | $23.1M | 9.5% | $3.68 | +155.7% | COM | 03237H101 |
| RZLT | REZOLUTE INC COM NEW | 2,451,809 | $23.05M | 9.5% | $4.03 | +65.3% | COM | 76200L309 |
| NKTR | NEKTAR THERAPEUTICS COM NEW | 300,000 | $17.07M | 7.0% | $33.10 | 0.0% | COM | 640268306 |
| ZURA | ZURA BIO LTD CLASS A ORD SHS | 3,815,930 | $16.52M | 6.8% | $5.64 | -68.1% | COM | G9TY5A101 |
| SLNO | SOLENO THERAPEUTICS INC | 225,000 | $15.21M | 6.3% | $74.14 | 0.0% | COM | 834203309 |
| ASND | ASCENDIS PHARMA A/S SPONSORED ADR | 75,000 | $14.91M | 6.1% | $198.81 | — | COM | 04351P101 |
| ABVX | ABIVAX SA SPONSORED ADS | 150,000 | $12.73M | 5.3% | $12.06 | — | COM | 00370M103 |
| APGE | APOGEE THERAPEUTICS INC | 304,000 | $12.08M | 5.0% | $38.18 | 0.0% | COM | 03770N101 |
| DNTH | DIANTHUS THERAPEUTICS INC | 265,803 | $10.46M | 4.3% | $25.56 | 0.0% | COM | 252828108 |
| CYTK | CYTOKINETICS INC COM NEW | 150,000 | $8.244M | 3.4% | $51.61 | -20.2% | COM | 23282W605 |
| IMVT | IMMUNOVANT INC | 500,000 | $8.06M | 3.3% | $18.67 | -13.3% | COM | 45258J102 |
| XENE | XENON PHARMACEUTICALS INC | 200,000 | $8.03M | 3.3% | $41.35 | -14.8% | COM | 98420N105 |
| NGNE | NEUROGENE INC | 446,814 | $7.743M | 3.2% | $14.71 | +36.5% | COM | 64135M105 |
| EPRX | EUPRAXIA PHARMACEUTICALS INC | 1,200,000 | $7.08M | 2.9% | $5.44 | 0.0% | COM | 29842P105 |
| UPB | UPSTREAM BIO INC | 300,000 | $5.643M | 2.3% | $22.33 | -30.4% | COM | 91678A107 |
| JBIO | JADE BIOSCIENCES INC COM NEW | 632,599 | $5.459M | 2.3% | $27.97 | -70.8% | COM | 008064206 |
| IONS | IONIS PHARMACEUTICALS INC | 80,000 | $5.234M | 2.2% | $35.97 | +35.7% | COM | 462222100 |
| — | AKERO THERAPEUTICS INC | 103,848 | $4.931M | 2.0% | $53.36 | — | COM | 00973Y108 |
| TSHA | TAYSHA GENE THERAPIES INC COM SHS | 1,500,000 | $4.905M | 2.0% | $2.17 | +30.3% | COM | 877619106 |
| CNTX | CONTEXT THERAPEUTICS INC | 4,683,711 | $4.538M | 1.9% | $1.72 | -53.0% | COM | 21077P108 |
| PHVS | PHARVARIS N V | 155,105 | $3.87M | 1.6% | $22.18 | 0.0% | COM | N69605108 |
| DBVT | DBV TECHNOLOGIES S A SPONSORED ADS | 378,594 | $3.786M | 1.6% | $9.17 | — | COM | 23306J309 |
| LEGN | LEGEND BIOTECH CORP SPONSORED ADS | 113,460 | $3.7M | 1.5% | $34.87 | — | COM | 52490G102 |
| ORKA | ORUKA THERAPEUTICS INC | 183,330 | $3.525M | 1.5% | $14.82 | 0.0% | COM | 687604108 |
| UNCY | UNICYCIVE THERAPEUTICS INC COM NEW | 796,558 | $3.473M | 1.4% | $6.18 | -29.5% | COM | 90466Y202 |
| SANA | SANA BIOTECHNOLOGY INC | 700,000 | $2.485M | 1.0% | $3.62 | 0.0% | COM | 799566104 |
| ABSI | ABSCI CORPORATION | 796,438 | $2.421M | 1.0% | $2.76 | 0.0% | COM | 00091E109 |
| HRMY | HRMY 10/17/2025 40 Call | 85,000 | $2.343M | 1.0% | — | — | Call | 413197104 |
| PLRX | PLIANT THERAPEUTICS INC | 850,000 | $1.258M | 0.5% | $16.18 | -90.6% | COM | 729139105 |
| CAPR | CAPR 12/19/2025 7.5 Put | 87,700 | $632K | 0.3% | — | — | Put | 14070B309 |